Iatrogenic Hyperviscosity and Thrombosis

 

 Buy Article Permissions and Reprints

Abstract

It is well known that hemostatic–thrombotic mechanisms are influenced by hemodynamic factors, such as shear forces affecting platelets or red blood cell aggregation, in turn affecting flow in stenotic regions. Endothelial cell function is also significantly influenced by shear forces acting on the vessel wall. Further, the distribution of shear forces in the vasculature is complex and closely associated with factors determining the flow properties of blood. Therefore, there is a link among alterations in the rheological properties of blood and its elements and the risk for thrombosis, with this linkage confirmed by numerous clinical studies. After discussing relevant rheological and hemodynamic concepts, this review focuses on selected drug-induced conditions that are known to be associated with both hyperviscosity conditions and increased thrombotic risk: oral contraceptives, diuretics, intravenous immunoglobulin, erythropoiesis-stimulating agents, chemotherapy, and radio-contrast media. Alterations of relationships between blood rheology and thrombotic risk related to artificial circulatory environments and physical exercise are also briefly discussed.

• References

• 1 Cokelet GR. Hemorheology and Hemodynamics. San Francisco, CA: Morgan & Claypool Life Sciences; 2011
  Google Scholar
• 2 Cokelet GR, Meiselman HJ. Macro- and micro-rheological properties of blood. In: Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ, eds. Handbook of Hemorheology and Hemodynamics. Amsterdam, Netherlands: IOS Press; 2007: 45-71
  Google Scholar
• 3 Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2003; 29 (5) 435-450
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Mohandas N, Chasis JA. Red blood cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin Hematol 1993; 30 (3) 171-192
  PubMedGoogle Scholar
• 5 Takakuwa Y, Ishibashi T, Mohandas N. Regulation of red cell membrane deformability and stability by skeletal protein network. Biorheology 1990; 27 (3–4) 357-365
  PubMedGoogle Scholar
• 6 Chien S. Red cell deformability and its relevance to blood flow. Annu Rev Physiol 1987; 49: 177-192
  CrossrefPubMedGoogle Scholar
• 7 Alexy T, Sangkatumvong S, Connes P , et al. Sickle cell disease: selected aspects of pathophysiology. Clin Hemorheol Microcirc 2010; 44 (3) 155-166
  PubMedGoogle Scholar
• 8 Vayá A, Iborra J, Falcó C , et al. Rheological behaviour of red blood cells in beta and deltabeta thalassemia trait. Clin Hemorheol Microcirc 2003; 28 (2) 71-78
  PubMedGoogle Scholar
• 9 Baskurt OK. Mechanisms of blood rheology alterations. In: Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ, eds. Handbook of Hemorheology and Hemodynamics. Amsterdam, Netherlands: IOS Press; 2007: 170-190
  Google Scholar
• 10 Baskurt OK, Temiz A, Meiselman HJ. Effect of superoxide anions on red blood cell rheologic properties. Free Radic Biol Med 1998; 24 (1) 102-110
  CrossrefPubMedGoogle Scholar
• 11 Hebbel RP, Leung A, Mohandas N. Oxidation-induced changes in microrheologic properties of the red blood cell membrane. Blood 1990; 76 (5) 1015-1020
  PubMedGoogle Scholar
• 12 Baskurt OK, Neu B, Meiselman HJ. Red Blood Cell Aggregation. Boca Raton, Florida: CRC Press; 2011
  CrossrefGoogle Scholar
• 13 Rampling MW, Meiselman HJ, Neu B, Baskurt OK. Influence of cell-specific factors on red blood cell aggregation. Biorheology 2004; 41 (2) 91-112
  PubMedGoogle Scholar
• 14 Alt E, Amann-Vesti BR, Madl C, Funk G, Koppensteiner R. Platelet aggregation and blood rheology in severe sepsis/septic shock: relation to the Sepsis-related Organ Failure Assessment (SOFA) score. Clin Hemorheol Microcirc 2004; 30 (2) 107-115
  PubMedGoogle Scholar
• 15 Baskurt OK, Temiz A, Meiselman HJ. Red blood cell aggregation in experimental sepsis. J Lab Clin Med 1997; 130 (2) 183-190
  CrossrefPubMedGoogle Scholar
• 16 Berliner AS, Shapira I, Rogowski O , et al. Combined leukocyte and erythrocyte aggregation in the peripheral venous blood during sepsis. An indication of commonly shared adhesive protein(s). Int J Clin Lab Res 2000; 30 (1) 27-31
  CrossrefPubMedGoogle Scholar
• 17 Chong-Martinez B, Buchanan TA, Wenby RB, Meiselman HJ. Decreased red blood cell aggregation subsequent to improved glycaemic control in Type 2 diabetes mellitus. Diabet Med 2003; 20 (4) 301-306
  CrossrefPubMedGoogle Scholar
• 18 Zilberman-Kravits D, Harman-Boehm I, Shuster T, Meyerstein N. Increased red cell aggregation is correlated with HbA1C and lipid levels in type 1 but not type 2 diabetes. Clin Hemorheol Microcirc 2006; 35 (4) 463-471
  PubMedGoogle Scholar
• 19 Cicco G, Pirrelli A. Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension. Clin Hemorheol Microcirc 1999; 21 (3–4) 169-177
  PubMedGoogle Scholar
• 20 Lebensohn N, Re A, Carrera L, Barberena L, D'Arrigo M, Foresto P. [Serum sialic acid, cellular anionic charge and erythrocyte aggregation in diabetic and hypertensive patients]. Medicina (B Aires) 2009; 69 (3) 331-334
  PubMedGoogle Scholar
• 21 Reneman RS, Arts T, Hoeks APG. Wall shear stress—an important determinant of endothelial cell function and structure—in the arterial system in vivo. Discrepancies with theory. J Vasc Res 2006; 43 (3) 251-269
  CrossrefPubMedGoogle Scholar
• 22 Katritsis D, Kaiktsis L, Chaniotis A, Pantos J, Efstathopoulos EP, Marmarelis V. Wall shear stress: theoretical considerations and methods of measurement. Prog Cardiovasc Dis 2007; 49 (5) 307-329
  CrossrefPubMedGoogle Scholar
• 23 Bishop JJ, Popel AS, Intaglietta M, Johnson PC. Effects of erythrocyte aggregation and venous network geometry on red blood cell axial migration. Am J Physiol Heart Circ Physiol 2001; 281 (2) H939-H950
  PubMedGoogle Scholar
• 24 Bishop JJ, Popel AS, Intaglietta M, Johnson PC. Effect of aggregation and shear rate on the dispersion of red blood cells flowing in venules. Am J Physiol Heart Circ Physiol 2002; 283 (5) H1985-H1996
  PubMedGoogle Scholar
• 25 Gaehtgens P, Meiselman HJ, Wayland H. Velocity profiles of human blood at normal and reduced hematocrit in glass tubes up to 130 diameter. Microvasc Res 1970; 2 (1) 13-23
  CrossrefPubMedGoogle Scholar
• 26 Goldsmith HL, Cokelet GR, Gaehtgens P. Robin Fåhraeus: evolution of his concepts in cardiovascular physiology. Am J Physiol 1989; 257 (3 pt 2) H1005-H1015
  PubMedGoogle Scholar
• 27 Ong PK, Jain S, Kim S. Temporal variations of the cell-free layer width may enhance NO bioavailability in small arterioles: effects of erythrocyte aggregation. Microvasc Res 2011; 81 (3) 303-312
  CrossrefPubMedGoogle Scholar
• 28 Goldsmith HL, Bell DN, Spain S, McIntosh FA. Effect of red blood cells and their aggregates on platelets and white cells in flowing blood. Biorheology 1999; 36 (5–6) 461-468
  PubMedGoogle Scholar
• 29 Nash GB, Watts T, Thornton C, Barigou M. Red cell aggregation as a factor influencing margination and adhesion of leukocytes and platelets. Clin Hemorheol Microcirc 2008; 39 (1–4) 303-310
  PubMedGoogle Scholar
• 30 Bishop JJ, Popel AS, Intaglietta M, Johnson PC. Rheological effects of red blood cell aggregation in the venous network: a review of recent studies. Biorheology 2001; 38 (2–3) 263-274
  PubMedGoogle Scholar
• 31 Bishop JJ, Nance PR, Popel AS, Intaglietta M, Johnson PC. Effect of erythrocyte aggregation on velocity profiles in venules. Am J Physiol Heart Circ Physiol 2001; 280 (1) H222-H236
  PubMedGoogle Scholar
• 32 Rampling MW. Hyperviscosity as a complication in a variety of disorders. Semin Thromb Hemost 2003; 29 (5) 459-465
  Article in Thieme ConnectPubMedGoogle Scholar
• 33 Isbister JP. Hyperviscosity: clinical disorders. In: Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ, eds. Handbook of Hemorheology and Hemodynamics. Amsterdam, Netherlands: IOS Press; 2007: 371-391
  Google Scholar
• 34 Kwaan HC, Wang J. Hyperviscosity in polycythemia vera and other red cell abnormalities. Semin Thromb Hemost 2003; 29 (5) 451-458
  Article in Thieme ConnectPubMedGoogle Scholar
• 35 Kwaan HC, Bongu A. The hyperviscosity syndromes. Semin Thromb Hemost 1999; 25 (2) 199-208
  Article in Thieme ConnectPubMedGoogle Scholar
• 36 Kwaan HC. Role of plasma proteins in whole blood viscosity: a brief clinical review. Clin Hemorheol Microcirc 2010; 44 (3) 167-176
  PubMedGoogle Scholar
• 37 Tsai HM. Shear stress and von Willebrand factor in health and disease. Semin Thromb Hemost 2003; 29 (5) 479-488
  Article in Thieme ConnectPubMedGoogle Scholar
• 38 Di Stasio E, De Cristofaro R. The effect of shear stress on protein conformation: physical forces operating on biochemical systems: the case of von Willebrand factor. Biophys Chem 2010; 153 (1) 1-8
  CrossrefPubMedGoogle Scholar
• 39 Anderson GH, Hellums JD, Moake J, Alfrey Jr CP. Platelet response to shear stress: changes in serotonin uptake, serotonin release, and ADP induced aggregation. Thromb Res 1978; 13 (6) 1039-1047
  CrossrefPubMedGoogle Scholar
• 40 Colantuoni G, Hellums JD, Moake JL, Alfrey Jr CP. The response of human platelets to shear stress at short exposure times. Trans Am Soc Artif Intern Organs 1977; 23: 626-631
  CrossrefPubMedGoogle Scholar
• 41 Jesty J, Yin W, Perrotta P, Bluestein D. Platelet activation in a circulating flow loop: combined effects of shear stress and exposure time. Platelets 2003; 14 (3) 143-149
  CrossrefPubMedGoogle Scholar
• 42 Nobili M, Sheriff J, Morbiducci U, Redaelli A, Bluestein D. Platelet activation due to hemodynamic shear stresses: damage accumulation model and comparison to in vitro measurements. ASAIO J 2008; 54 (1) 64-72
  CrossrefPubMedGoogle Scholar
• 43 Rubenstein DA, Yin W. Quantifying the effects of shear stress and shear exposure duration regulation on flow induced platelet activation and aggregation. J Thromb Thrombolysis 2010; 30 (1) 36-45
  CrossrefPubMedGoogle Scholar
• 44 Hellums JD. 1993 Whitaker Lecture: biorheology in thrombosis research. Ann Biomed Eng 1994; 22 (5) 445-455
  CrossrefPubMedGoogle Scholar
• 45 Nesbitt WS, Mangin P, Salem HH, Jackson SP. The impact of blood rheology on the molecular and cellular events underlying arterial thrombosis. J Mol Med (Berl) 2006; 84 (12) 989-995
  CrossrefPubMedGoogle Scholar
• 46 Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996; 88 (5) 1525-1541
  PubMedGoogle Scholar
• 47 Nesbitt WS, Kulkarni S, Giuliano S , et al. Distinct glycoprotein Ib/V/IX and integrin alpha IIbbeta 3-dependent calcium signals cooperatively regulate platelet adhesion under flow. J Biol Chem 2002; 277 (4) 2965-2972
  CrossrefPubMedGoogle Scholar
• 48 Sheriff J, Bluestein D, Girdhar G, Jesty J. High-shear stress sensitizes platelets to subsequent low-shear conditions. Ann Biomed Eng 2010; 38 (4) 1442-1450
  CrossrefPubMedGoogle Scholar
• 49 Michiels C. Endothelial cell functions. J Cell Physiol 2003; 196 (3) 430-443
  CrossrefPubMedGoogle Scholar
• 50 Toborek M, Kaiser S. Endothelial cell functions. Relationship to atherogenesis. Basic Res Cardiol 1999; 94 (5) 295-314
  CrossrefPubMedGoogle Scholar
• 51 Chien S. Molecular basis of rheological modulation of endothelial functions: importance of stress direction. Biorheology 2006; 43 (2) 95-116
  PubMedGoogle Scholar
• 52 Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev 2011; 91 (1) 327-387
  CrossrefPubMedGoogle Scholar
• 53 Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999; 282 (21) 2035-2042
  CrossrefPubMedGoogle Scholar
• 54 Traub O, Berk BC. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 1998; 18 (5) 677-685
  CrossrefPubMedGoogle Scholar
• 55 Varin R, Mulder P, Richard V , et al. Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress. Circulation 1999; 99 (22) 2951-2957
  CrossrefPubMedGoogle Scholar
• 56 Tsai AG, Friesenecker B, McCarthy M, Sakai H, Intaglietta M. Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am J Physiol 1998; 275 (6 pt 2) H2170-H2180
  PubMedGoogle Scholar
• 57 Tsai AG, Acero C, Nance PR , et al. Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion. Am J Physiol Heart Circ Physiol 2005; 288 (4) H1730-H1739
  PubMedGoogle Scholar
• 58 Baskurt OK, Yalcin O, Ozdem S, Armstrong JK, Meiselman HJ. Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation. Am J Physiol Heart Circ Physiol 2004; 286 (1) H222-H229
  CrossrefPubMedGoogle Scholar
• 59 Yalcin O, Ulker P, Yavuzer U, Meiselman HJ, Baskurt OK. Nitric oxide generation by endothelial cells exposed to shear stress in glass tubes perfused with red blood cell suspensions: role of aggregation. Am J Physiol Heart Circ Physiol 2008; 294 (5) H2098-H2105
  CrossrefPubMedGoogle Scholar
• 60 von Tempelhoff GF, Nieman F, Heilmann L, Hommel G. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy. Clin Hemorheol Microcirc 2000; 22 (2) 107-130
  PubMedGoogle Scholar
• 61 von Tempelhoff GF, Heilmann L, Hommel G, Pollow K. Impact of rheological variables in cancer. Semin Thromb Hemost 2003; 29 (5) 499-513
  Article in Thieme ConnectPubMedGoogle Scholar
• 62 Cao M, Olsen RJ, Zu Y. Polycythemia vera: new clinicopathologic perspectives. Arch Pathol Lab Med 2006; 130 (8) 1126-1132
  PubMedGoogle Scholar
• 63 Tefferi A, Spivak JL. Polycythemia vera: scientific advances and current practice. Semin Hematol 2005; 42 (4) 206-220
  CrossrefPubMedGoogle Scholar
• 64 Landolfi R, Nicolazzi MA, Porfidia A, Di Gennaro L. Polycythemia vera. Intern Emerg Med 2010; 5 (5) 375-384
  CrossrefPubMedGoogle Scholar
• 65 Barbui T, Finazzi G. Evidence-based management of polycythemia vera. Best Pract Res Clin Haematol 2006; 19 (3) 483-493
  CrossrefPubMedGoogle Scholar
• 66 Fahraeus R. The influence of the rouleau formation of the erythrocytes on the rheology of the blood. Acta Med Scand 1958; 161 (2) 151-165
  PubMedGoogle Scholar
• 67 Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001; 88 (8) 756-762
  CrossrefPubMedGoogle Scholar
• 68 Landolfi R, Cipriani MC, Novarese L. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention. Best Pract Res Clin Haematol 2006; 19 (3) 617-633
  CrossrefPubMedGoogle Scholar
• 69 Garcia D, Quintana D. Thrombosis and malignancy: a case-based review. Semin Hematol 2011; 48 (4) 259-263
  CrossrefPubMedGoogle Scholar
• 70 Zahra S, Anderson JAM, Stirling D, Ludlam CA. Microparticles, malignancy and thrombosis. Br J Haematol 2011; 152 (6) 688-700
  CrossrefPubMedGoogle Scholar
• 71 Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996; 2 (2) 209-215
  CrossrefPubMedGoogle Scholar
• 72 Zacharski LR, Memoli VA, Ornstein DL, Rousseau SM, Kisiel W, Kudryk BJ. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. J Natl Cancer Inst 1993; 85 (15) 1225-1230
  CrossrefPubMedGoogle Scholar
• 73 Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998; 55 (11) 1475-1482
  CrossrefPubMedGoogle Scholar
• 74 Sedlaczek O, Caplan L, Hennerici M. Impaired washout—embolism and ischemic stroke: further examples and proof of concept. Cerebrovasc Dis 2005; 19 (6) 396-401
  CrossrefPubMedGoogle Scholar
• 75 Döring A, Fröhlich M, Löwel H, Koenig W. Third generation oral contraceptive use and cardiovascular risk factors. Atherosclerosis 2004; 172 (2) 281-286
  CrossrefPubMedGoogle Scholar
• 76 Basaria S, Nguyen T, Rosenson RS, Dobs AS. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women. Clin Endocrinol (Oxf) 2002; 57 (2) 209-214
  CrossrefPubMedGoogle Scholar
• 77 El Bouhmadi A, Laffargue F, Raspal N, Brun JF. 100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives. Clin Hemorheol Microcirc 2000; 22 (2) 99-106
  PubMedGoogle Scholar
• 78 Ernst E, Schmölzl C, Matrai A, Schramm W. Hemorheological effects of oral contraceptives. Contraception 1989; 40 (5) 571-580
  CrossrefPubMedGoogle Scholar
• 79 Solerte SB, Fioravanti M, Spinillo A, Ferrari E, Guaschino S. Influence of triphasic oral contraceptives on blood rheology and hemostatic and metabolic patterns in young women. Results of a three-year study. J Reprod Med 1992; 37 (8) 725-732
  PubMedGoogle Scholar
• 80 Coata G, Ventura F, Lombardini R, Ciuffetti G, Cosmi EV, Di Renzo GC. Effect of low-dose oral triphasic contraceptives on blood viscosity, coagulation and lipid metabolism. Contraception 1995; 52 (3) 151-157
  CrossrefPubMedGoogle Scholar
• 81 Ishak R, Khim LC. Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit. Malays J Reprod Health 1991; 9 (1) 5-8
  PubMedGoogle Scholar
• 82 Lowe GDO, Drummond MM, Forbes CD, Barbenel JC. Increased blood viscosity in young women using oral contraceptives. Am J Obstet Gynecol 1980; 137 (7) 840-842
  PubMedGoogle Scholar
• 83 Buchan PC, Macdonald HN. Altered haemorheology in oral-contraceptive users. BMJ 1980; 280 (6219) 978-979
  CrossrefPubMedGoogle Scholar
• 84 Durocher JR, Weir MS, Lundblad EG, Patow WE, Conrad ME. Effect of oral contraceptives and pregnancy on erythrocyte deformability and surface charge. Proc Soc Exp Biol Med 1975; 150 (2) 368-370
  PubMedGoogle Scholar
• 85 Reiner JS. Contrast media and clotting: what is the evidence?. Catheter Cardiovasc Interv 2010; 75 (Suppl. 01) S35-S38
  CrossrefPubMedGoogle Scholar
• 86 Hardeman MR, Goedhart P, Koen IY. The effect of low-osmolar ionic and nonionic contrast media on human blood viscosity, erythrocyte morphology, and aggregation behavior. Invest Radiol 1991; 26 (9) 810-819
  CrossrefPubMedGoogle Scholar
• 87 Laurent A, Durussel JJ, Dufaux J , et al. Effects of contrast media on blood rheology: comparison in humans, pigs, and sheep. Cardiovasc Intervent Radiol 1999; 22 (1) 62-66
  CrossrefPubMedGoogle Scholar
• 88 Reinhart WH, Pleisch B, Harris LG, Lütolf M. Influence of contrast media (iopromide, ioxaglate, gadolinium-DOTA) on blood viscosity, erythrocyte morphology and platelet function. Clin Hemorheol Microcirc 2005; 32 (3) 227-239
  PubMedGoogle Scholar
• 89 Smedby O. Viscosity of some contemporary contrast media before and after mixing with whole blood. Acta Radiol 1992; 33 (6) 600-605
  PubMedGoogle Scholar
• 90 Scheller B, Hennen B, Thünenkötter T , et al. Effect of X-ray contrast media on blood flow properties after coronary angiography. Thromb Res 1999; 96 (4) 253-260
  CrossrefPubMedGoogle Scholar
• 91 Spitzer S, Münster W, Sternitzky R, Bach R, Jung F. Influence of Iodixanol-270 and Iopentol-150 on the microcirculation in man: influence of viscosity on capillary perfusion. Clin Hemorheol Microcirc 1999; 20 (1) 49-55
  PubMedGoogle Scholar
• 92 Spencer CG, Felmeden DC, Blann AD, Lip GY. Effects of “newer” and “older” antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Am J Hypertens 2007; 20 (6) 699-704
  CrossrefPubMedGoogle Scholar
• 93 Muravyov AV, Yakusevich VV, Kabanov AV, Petrochenko AS. The effect of diuretics on red blood cell microrheological parameters in female hypertensive patients. Clin Hemorheol Microcirc 2005; 33 (2) 121-126
  PubMedGoogle Scholar
• 94 Khder Y, Bray des Boscs L, el Ghawi R , et al. Calcium antagonists and thiazide diuretics have opposite effects on blood rheology and radial artery compliance in arterial hypertension: a randomized double-blind study. Fundam Clin Pharmacol 1998; 12 (4) 457-462
  CrossrefPubMedGoogle Scholar
• 95 Zannad F, Bray-Desboscs L, el Ghawi R, Donner M, Thibout E, Stoltz JF. Effects of lisinopril and hydrochlorothiazide on platelet function and blood rheology in essential hypertension: a randomly allocated double-blind study. J Hypertens 1993; 11 (5) 559-564
  CrossrefPubMedGoogle Scholar
• 96 Koenig W, Sund M, Ernst E , et al. Effects of felodipine ER and hydrochlorothiazide on blood rheology in essential hypertension—a randomized, double-blind, crossover study. J Intern Med 1991; 229 (6) 533-538
  CrossrefPubMedGoogle Scholar
• 97 Andrews RJ, Bringas JR, Muto RP. Effects of mannitol on cerebral blood flow, blood pressure, blood viscosity, hematocrit, sodium, and potassium. Surg Neurol 1993; 39 (3) 218-222
  CrossrefPubMedGoogle Scholar
• 98 Muravyov AV, Meiselman HJ, Yakusevich VV, Zamishlayev AV. Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity. Clin Hemorheol Microcirc 2002; 26 (2) 125-135
  PubMedGoogle Scholar
• 99 Bird J, Carmona C. Probable interaction between warfarin and torsemide. Ann Pharmacother 2008; 42 (12) 1893-1898
  CrossrefPubMedGoogle Scholar
• 100 Laizure SC, Madlock L, Cyr M, Self T. Decreased hypoprothrombinemic effect of warfarin associated with furosemide. Ther Drug Monit 1997; 19 (3) 361-363
  CrossrefPubMedGoogle Scholar
• 101 Kaşifoğlu T, Yalçin AU. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters. Anadolu Kardiyol Derg 2006; 6 (2) 143-147
  PubMedGoogle Scholar
• 102 Lottermoser K, Hertfelder HJ, Vetter H, Düsing R. Fibrinolytic function in diuretic-induced volume depletion. Am J Hypertens 2000; 13 (4 Pt 1) 359-363
  CrossrefPubMedGoogle Scholar
• 103 Bentley P, Rosso M, Sadnicka A, Israeli-Korn S, Laffan M, Sharma P. Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure. J Clin Pharm Ther 2012; 37 (3) 286-290
  CrossrefPubMedGoogle Scholar
• 104 Dalakas MC. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology 1994; 44 (2) 223-226
  CrossrefPubMedGoogle Scholar
• 105 Kowal P, Zmyślony A. Hemorheological changes after intravenous gammaglobulin administration in patients with neurological disorders. Clin Hemorheol Microcirc 2008; 40 (3) 229-234
  PubMedGoogle Scholar
• 106 Baba R, Shibata A, Tsurusawa M. Single high-dose intravenous immunoglobulin therapy for kawasaki disease increases plasma viscosity. Circ J 2005; 69 (8) 962-964
  CrossrefPubMedGoogle Scholar
• 107 Ben-Ami R, Barshtein G, Mardi T , et al. A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation. Am J Physiol Heart Circ Physiol 2003; 285 (6) H2663-H2669
  PubMedGoogle Scholar
• 108 Game L, Voegel JC, Schaaf P, Stoltz JF. Do physiological concentrations of IgG induce a direct aggregation of red blood cells: comparison with fibrinogen. Biochim Biophys Acta 1996; 1291 (2) 138-142
  CrossrefPubMedGoogle Scholar
• 109 Macdougall IC, Davies ME, Hutton RD, Coles GA, Williams JD. Rheological studies during treatment of renal anaemia with recombinant human erythropoietin. Br J Haematol 1991; 77 (4) 550-558
  PubMedGoogle Scholar
• 110 Nowicki M. Erythropoietin and hypertension. J Hum Hypertens 1995; 9 (2) 81-88
  PubMedGoogle Scholar
• 111 Crowley JP, Chazan JA, Metzger JB, Pono L, Valeri CR. Blood rheology and 2,3-diphosphoglycerate levels after erythropoietin treatment. Ann Clin Lab Sci 1993; 23 (1) 24-32
  PubMedGoogle Scholar
• 112 Delamaire M, Durand F, Hamel D, Joyeux V, Lepogamp P, Genetet B. [Improvement of hemorheologic parameters in hemodialyzed patients treated with human recombinant erythropoietin]. J Mal Vasc 1991; 16 (3) 289-294
  PubMedGoogle Scholar
• 113 Hassan K, Roguin N, Kaganov Y, Hasan S, Kristal B. Effect of erythropoietin therapy on red cells filterability and left ventricular mass in predialysis patients. Ren Fail 2005; 27 (2) 177-182
  PubMedGoogle Scholar
• 114 Singh A, Eckardt KU, Zimmermann A , et al. Increased plasma viscosity as a reason for inappropriate erythropoietin formation. J Clin Invest 1993; 91 (1) 251-256
  CrossrefPubMedGoogle Scholar
• 115 Bor-Kucukatay M, Yalcin O, Meiselman HJ, Baskurt OK. Erythropoietin-induced rheological changes of rat erythrocytes. Br J Haematol 2000; 110 (1) 82-88
  CrossrefPubMedGoogle Scholar
• 116 Vaziri ND, Ritchie C, Brown P , et al. Effect of erythropoietin administration on blood and plasma viscosity in hemodialysis patients. ASAIO Trans 1989; 35 (3) 505-508
  CrossrefPubMedGoogle Scholar
• 117 Shinaberger JH, Miller JH, Gardner PW. Erythropoietin alert: risks of high hematocrit hemodialysis. ASAIO Trans 1988; 34 (3) 179-184
  PubMedGoogle Scholar
• 118 Lippi G, Franchini M, Favaloro EJ. Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost 2010; 36 (5) 537-549
  Article in Thieme ConnectPubMedGoogle Scholar
• 119 von Tempelhoff GF, Niemann F, Schneider DM, Kirkpatrick CJ, Hommel G, Heilmann L. Blood rheology during chemotherapy in patients with ovarian cancer. Thromb Res 1998; 90 (2) 73-82
  CrossrefPubMedGoogle Scholar
• 120 von Tempelhoff GF, Heilmann L, Pollow K, Hommel G. Monitoring of rheologic variables during postoperative high-dose brachytherapy for uterine cancer. Clin Appl Thromb Hemost 2004; 10 (3) 239-248
  CrossrefPubMedGoogle Scholar
• 121 Kameneva MV, Antaki JF. Mechanical trauma to blood. In: Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ, eds. Handbook of Hemorheology and Hemodynamics. Amsterdam, Netherlands: IOS Press; 2007: 206-227
  Google Scholar
• 122 Hirayama T, Roberts D, William-Olsson G. Mechanical trauma to red blood cells caused by Björk-Shiley and Carpentier-Edwards heart valves. Scand J Thorac Cardiovasc Surg 1985; 19 (3) 253-256
  CrossrefPubMedGoogle Scholar
• 123 Hirayama T, Yamaguchi H, Allers M, Roberts D, William-Olsson G. Changes in red cell deformability associated with anaesthesia and cardiopulmonary bypass in open-heart surgery. Scand J Thorac Cardiovasc Surg 1985; 19 (3) 257-262
  CrossrefPubMedGoogle Scholar
• 124 Vaisman S, Kensey K, Cho YI. Effect of hemodialysis on whole blood viscosity. Int J Artif Organs 2009; 32 (6) 329-335
  PubMedGoogle Scholar
• 125 Martínez M, Vayá A, Alvariño J , et al. Hemorheological alterations in patients with chronic renal failure. Effect of hemodialysis. Clin Hemorheol Microcirc 1999; 21 (1) 1-6
  PubMedGoogle Scholar
• 126 Dhar P, Eadon M, Hallak P, Munoz RA, Hammes M. Whole blood viscosity: effect of hemodialysis treatment and implications for access patency and vascular disease. Clin Hemorheol Microcirc 2012; . In press
  PubMedGoogle Scholar
• 127 Ibrahim FF, Ghannam MM, Ali FM. Effect of dialysis on erythrocyte membrane of chronically hemodialyzed patients. Ren Fail 2002; 24 (6) 779-790
  CrossrefPubMedGoogle Scholar
• 128 Kameneva MV, Marad PF, Brugger JM , et al. In vitro evaluation of hemolysis and sublethal blood trauma in a novel subcutaneous vascular access system for hemodialysis. ASAIO J 2002; 48 (1) 34-38
  CrossrefPubMedGoogle Scholar
• 129 Ocak G, Vossen CY, Rotmans JI , et al. Venous and arterial thrombosis in dialysis patients. Thromb Haemost 2011; 106 (6) 1046-1052
  Article in Thieme ConnectPubMedGoogle Scholar
• 130 Minneci PC, Deans KJ, Zhi H , et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 2005; 115 (12) 3409-3417
  CrossrefPubMedGoogle Scholar
• 131 Connes P, Brun JF, Baskurt OK. Blood rheology and exercise. In: Connes P, Hue O, Perrey S, eds. Exercise Physiology: From a Cellular to an Integrative Approach. Amsterdam, Netherlands: IOS Press; 2010: 213-229
  Google Scholar
• 132 Vandewalle H, Lacombe C, Lelièvre JC, Poirot C. Blood viscosity after a 1-h submaximal exercise with and without drinking. Int J Sports Med 1988; 9 (2) 104-107
  Article in Thieme ConnectPubMedGoogle Scholar
• 133 Yalcin O, Erman A, Muratli S, Bor-Kucukatay M, Baskurt OK. Time course of hemorheological alterations after heavy anaerobic exercise in untrained human subjects. J Appl Physiol 2003; 94 (3) 997-1002
  CrossrefPubMedGoogle Scholar
• 134 Ernst E, Daburger L, Saradeth T. The kinetics of blood rheology during and after prolonged standardized exercise. Clin Hemorheol 1991; 11: 429-439
  PubMedGoogle Scholar
• 135 Brun JF, Belhabas H, Granat MCh , et al. Postexercise red cell aggregation is negatively correlated with blood lactate rate of disappearance. Clin Hemorheol Microcirc 2002; 26 (4) 231-239
  PubMedGoogle Scholar
• 136 Gaudard A, Varlet-Marie E, Monnier JF , et al. Exercise-induced central retinal vein thrombosis: possible involvement of hemorheological disturbances. A case report. Clin Hemorheol Microcirc 2002; 27 (2) 115-122
  PubMedGoogle Scholar
• 137 Connes P, Tripette J, Chalabi T , et al. Effects of strenuous exercise on blood coagulation activity in sickle cell trait carriers. Clin Hemorheol Microcirc 2008; 38 (1) 13-21
  PubMedGoogle Scholar
• 138 El-Sayed MS, Nagia A. Blood hemostasis in exercise and training. In: Connes P, Hue O, Perrey S, eds. Exercise Physiology: From a Cellular to an Integrative Approach. Amsterdam, Netherlands: IOS Press; 2010: 259-281
  Google Scholar
• 139 Lippi G, Maffulli N. Biological influence of physical exercise on hemostasis. Semin Thromb Hemost 2009; 35 (3) 269-276
  Article in Thieme ConnectPubMedGoogle Scholar
• 140 Ikarugi H, Shibata M, Shibata S, Ishii H, Taka T, Yamamoto J. High intensity exercise enhances platelet reactivity to shear stress and coagulation during and after exercise. Pathophysiol Haemost Thromb 2003; 33 (3) 127-133
  CrossrefPubMedGoogle Scholar
• 141 Connes P, Machado R, Hue O, Reid H. Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia. Clin Hemorheol Microcirc 2011; 49 (1–4) 151-163
  PubMedGoogle Scholar
• 142 Tripette J, Loko G, Samb A , et al. Effects of hydration and dehydration on blood rheology in sickle cell trait carriers during exercise. Am J Physiol Heart Circ Physiol 2010; 299 (3) H908-H914
  CrossrefPubMedGoogle Scholar
• 143 Lippi G, Banfi G. Doping and thrombosis in sports. Semin Thromb Hemost 2011; 37 (8) 918-928
  Article in Thieme ConnectPubMedGoogle Scholar
• 144 Leigh-Smith S. Blood boosting. Br J Sports Med 2004; 38 (1) 99-101
  CrossrefPubMedGoogle Scholar
• 145 Segura J, Ventura R, Pascual JA. Current strategic approaches for the detection of blood doping practices. Forensic Sci Int 2011; 213 (1–3) 42-48
  CrossrefPubMedGoogle Scholar
• 146 Gauthier J. [Blood doping and cardiovascular consequences]. Presse Med 2002; 31 (40) 1904-1908
  PubMedGoogle Scholar